Jan 16 (Reuters) - Elevai Labs Inc ELAB.O :
* ELEVAI LABS, INC. ACQUIRES WORLDWIDE LICENSE AGREEMENT FOR
PROPRIETARY STEM CELL MANUFACTURING TECHNOLOGY
* INMUNE BIO INC - UNDER DEAL, ELEVAI WILL MAKE AN INITIAL
DEPOSIT
FOR LICENSE IN TWO INSTALLMENTS OVER SIX MONTHS
* INMUNE BIO INC - UNDER AGREEMENT, ELEVAI WILL MAKE A
FINAL TECH
TRANSFER FEE WITHIN TWO YEARS OF EXECUTING AGREEMENT
* INMUNE BIO INC - UNDER DEAL, ELEVAI TO PAY NOMINAL ROYALTY
ON
SALE OF LICENSED TOPICAL COSMETIC PRODUCTS THAT ARE MANUFACTURED
USING "EMX" TECHNOLOGY
Source text for Eikon: ID:nGNX4p2pQR
Further company coverage: ELAB.O
((Reuters.Briefs@thomsonreuters.com;))